Outcomes of Autologous Stem Cell Transplant (ASCT) in Patients with t (11;14) Multiple Myeloma(MM)
Sign Up to like & getrecommendations! Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.486
Abstract: Introduction MM is a clonal disorder of malignant plasma cells. Standard of care for newly diagnosed MM is induction with triplet regimen chemotherapy followed by ASCT. Patients are stratified based on cytogenetic analysis as being… read more here.
Keywords: risk; newly diagnosed; high risk; standard risk ... See more keywords